Yan Liang — Nanjing University of Chinese Medicine

Area of research

Cancer Research · Genetics

Research interest

Research interests include Medicine, Internal medicine, Refractory (planetary science), Hematology, Solid tumor, and Cholesterol.

Recent publications

Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies

Journal of Hematology & Oncology 2025cited by 15position: middledoi

Efficacy of early rehabilitation nursing on the prognosis of China stroke patients: A systematic review and meta-analysis of randomized controlled trials

Geriatric Nursing 2025cited by 6position: middledoi

ORP2 regulates free cholesterol accumulation in hepatocytes during MASH

Hepatology Communications 2025cited by 2position: middledoi

SHR-A1811 plus adebrelimab in unresectable or metastatic triple-negative breast cancer: Results from a phase 1b/2 expansion cohort.

Journal of Clinical Oncology 2025cited by 1position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Cancer Research · Genetics →